Self-Regulatory Organizations; NYSE Arca, Inc.; Order Granting Approval of Proposed Rule Change as Modified by Amendment No. 2 Thereto Relating to the Use of Derivative Instruments by PIMCO Total Return Exchange Traded Fund, 44224-44229 [2014-17880]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
44224
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
Adviser will (a) set a Subadvised Series’
overall investment strategies, (b)
evaluate, select, and recommend
Subadvisers to manage all or a portion
of a Subadvised Series’ assets, and (c)
implement procedures reasonably
designed to ensure that Subadvisers
comply with a Subadvised Series’
investment objective, policies and
restrictions. Subject to review by the
Board, the Adviser will (a) when
appropriate, allocate and reallocate a
Subadvised Series’ assets among
multiple Subadvisers; and (b) monitor
and evaluate the performance of
Subadvisers.
4. A Subadvised Series will not make
any Ineligible Subadviser Changes
without such agreement, including the
compensation to be paid thereunder,
being approved by the shareholders of
the applicable Subadvised Series.
5. Subadvised Series will inform
shareholders of the hiring of a new
Subadviser within 90 days after the
hiring of the new Subadviser pursuant
to the Modified Notice and Access
Procedures.
6. At all times, at least a majority of
the Board will be Independent Board
Members, and the selection and
nomination of new or additional
Independent Board Members will be
placed within the discretion of the thenexisting Independent Board Members.
7. Independent Legal Counsel, as
defined in rule 0–1(a)(6) under the Act,
will be engaged to represent the
Independent Board Members. The
selection of such counsel will be within
the discretion of the then-existing
Independent Board Members.
8. The Adviser will provide the
Board, no less frequently than quarterly,
with information about the profitability
of the Adviser on a per Subadvised
Series basis. The information will reflect
the impact on profitability of the hiring
or termination of any Subadviser during
the applicable quarter.
9. Whenever a Subadviser is hired or
terminated, the Adviser will provide the
Board with information showing the
expected impact on the profitability of
the Adviser.
10. Whenever a Subadviser change is
proposed for a Subadvised Series with
an Affiliated Subadviser or a WhollyOwned Subadviser, the Board,
including a majority of the Independent
Board Members, will make a separate
finding, reflected in the Board minutes,
that such change is in the best interests
of the Subadvised Series and its
shareholders, and does not involve a
conflict of interest from which the
Adviser or the Affiliated Subadviser or
Wholly-Owned Subadviser derives an
inappropriate advantage.
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
11. No Board member or officer of a
Subadvised Series, or partner, director,
manager, or officer of the Adviser, will
own directly or indirectly (other than
through a pooled investment vehicle
that is not controlled by such person),
any interest in a Subadviser, except for
(i) ownership of interests in the Adviser
or any entity, other than a WhollyOwned Subadviser, that controls, is
controlled by, or is under common
control with the Adviser, or (ii)
ownership of less than 1% of the
outstanding securities of any class of
equity or debt of a publicly traded
company that is either a Subadviser or
an entity that controls, is controlled by,
or is under common control with a
Subadviser.
12. Each Subadvised Series will
disclose the Aggregate Fee Disclosure in
its registration statement.
13. In the event the Commission
adopts a rule under the Act providing
substantially similar relief to that
requested in the application, the
requested order will expire on the
effective date of that rule.
14. Any new Sub-Advisory
Agreement or any amendment to a
Subadvised Series’ existing Investment
Advisory Agreement or Sub-Advisory
Agreement that directly or indirectly
results in an increase in the aggregate
advisory fee rate payable by the
Subadvised Series will be submitted to
the Subadvised Series’ shareholders for
approval.
For the Commission, by the Division of
Investment Management, under delegated
authority.
Kevin M. O’Neill,
Deputy Secretary.
[FR Doc. 2014–17883 Filed 7–29–14; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–72666; File No. SR–
NYSEArca–2013–122]
Self-Regulatory Organizations; NYSE
Arca, Inc.; Order Granting Approval of
Proposed Rule Change as Modified by
Amendment No. 2 Thereto Relating to
the Use of Derivative Instruments by
PIMCO Total Return Exchange Traded
Fund
July 24, 2014.
I. Introduction
On November 6, 2013, NYSE Arca,
Inc. (‘‘Exchange’’ or ‘‘NYSE Arca’’) filed
with the Securities and Exchange
Commission (‘‘Commission’’), pursuant
to Section 19(b)(1) of the Securities
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Exchange Act of 1934 (‘‘Act’’) 1 and Rule
19b–4 thereunder,2 a proposed rule
change to amend the description of the
means of achieving the investment
objective applicable to the PIMCO Total
Return Exchange Traded Fund (‘‘Fund’’)
relating to its use of derivative
instruments. The proposed rule change
was published for comment in the
Federal Register on November 26,
2013.3 On January 9, 2014, the
Commission designated a longer period
within which to approve the proposed
rule change, disapprove the proposed
rule change, or institute proceedings to
determine whether to disapprove the
proposed rule change.4 On February 24,
2014, the Commission instituted
proceedings to determine whether to
approve or disapprove the proposed
rule change.5 On April 15, 2014, the
Exchange submitted Amendments No. 1
and 2 to the proposed rule change.6 On
May 21, 2014, pursuant to Section
19(b)(2) of the Act,7 the Commission
designated a longer period within which
to issue an order approving or
disapproving the proposed rule change.8
The Commission received no comments
1 15
U.S.C. 78s(b)(1).
CFR 240.19b–4.
3 See Securities Exchange Act Release No. 70905
(November 20, 2013), 78 FR 70610 (‘‘Notice’’).
4 See Securities Exchange Act Release No. 71271
(January 9, 2014), 79 FR 2736 (January 15, 2014).
The Commission determined that it was appropriate
to designate a longer period within which to take
action on the proposed rule change so that it has
sufficient time to consider the proposed rule
change. Accordingly, the Commission designated
February 24, 2014 as the date by which it should
approve, disapprove, or institute proceedings to
determine whether to disapprove the proposed rule
change.
5 See Securities Exchange Act Release No. 71606,
79 FR 11486 (February 28, 2014).
6 The Exchange submitted and subsequently
withdrew Amendment No. 1 to the proposed rule
change. In Amendment No. 2, the Exchange
provided additional details describing how the
contents of the portfolio composition of the Fund
would be disclosed on a daily basis. Specifically,
the Fund will disclose on the Fund’s Web site the
following information regarding each portfolio
holding, as applicable to the type of holding: ticker
symbol, CUSIP number or other identifier, if any;
a description of the holding (including the type of
holding, such as the type of swap); the identity of
the security, commodity, index or other asset or
instrument underlying the holding, if any; for
options, the option strike price; quantity held (as
measured by, for example, par value, notional value
or number of shares, contracts or units); maturity
date, if any; coupon rate, if any; effective date, if
any; market value of the holding; and the
percentage weighting of the holding in the Fund’s
portfolio. It also confirms that all other facts and
representations made in the Prior Release remain
unchanged. See infra, note 9. Amendment No. 2
provides clarification to the proposed rule change,
and because it does not materially affect the
substance of the proposed rule change, Amendment
No. 2 does not require notice and comment.
7 15 U.S.C. 78s(b)(1).
8 See Securities Exchange Act Release No. 72216,
79 FR 30680 (May 28, 2014).
2 17
E:\FR\FM\30JYN1.SGM
30JYN1
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
on the proposal. This order grants
approval of the proposed rule change.
mstockstill on DSK4VPTVN1PROD with NOTICES
II. Description of the Proposed Rule
Change
The Commission previously approved
the listing and trading of shares
(‘‘Shares’’) of the Fund under NYSE
Arca Equities Rule 8.600, which governs
the listing and trading of Managed Fund
Shares on the Exchange.9 The Shares are
offered by PIMCO ETF Trust (‘‘Trust’’),
a statutory trust organized under the
laws of the State of Delaware and
registered with the Commission as an
open-end management investment
company.10 The investment manager to
the Fund is Pacific Investment
Management Company LLC (‘‘PIMCO’’
or ‘‘Adviser’’).
In the Prior Release, the Exchange
stated that, consistent with the Trust’s
Exemptive Order, the Fund would not
invest in options contracts, futures
contracts, or swap agreements.11 In view
9 See Securities Exchange Act Release No. 66321
(February 3, 2012), 77 FR 6850 (February 9, 2012)
(SR–NYSEArca–2011–95) (‘‘Prior Order’’). See also
Securities Exchange Act Release No. 65988
(December 16, 2011), 76 FR 79741 (December 22,
2011) (SR–NYSEArca–2011–95) (‘‘Prior Notice,’’
and together with the Prior Order, collectively,
‘‘Prior Release’’).
10 The Exchange represents that the Trust is
registered under the Investment Company Act of
1940 (‘‘1940 Act’’). On October 29, 2012 the Trust
filed with the Commission the most recent posteffective amendment to its registration statement
under the Securities Act of 1933 and under the
1940 Act relating to the Fund (File Nos. 333–
155395 and 811–22250) (‘‘Registration Statement’’).
The Exchange further represents that the Trust has
obtained certain exemptive relief under the 1940
Act. See Investment Company Act Release No.
28993 (November 10, 2009) (File No. 812–13571)
(‘‘Exemptive Order’’).
11 On December 6, 2012, the staff of the
Commission’s Division of Investment Management
(‘‘IM’’) issued a no-action letter (‘‘No-Action
Letter’’) relating to the use of derivatives by
actively-managed exchange traded funds (‘‘ETFs’’).
See No-Action Letter dated December 6, 2012 from
Elizabeth G. Osterman, Associate Director, Office of
Exemptive Applications, IM. The No-Action Letter
stated that IM staff would no longer defer
consideration of exemptive requests under the 1940
Act relating to actively-managed ETFs that make
use of derivatives provided that they include
representations to address some of the concerns
expressed in the Commission’s March 2010 press
release. These representations are: (i) That the ETF’s
board periodically will review and approve the
ETF’s use of derivatives and how the ETF’s
investment adviser assesses and manages risk with
respect to the ETF’s use of derivatives; and (ii) that
the ETF’s disclosure of its use of derivatives in its
offering documents and periodic reports is
consistent with relevant Commission and staff
guidance. The No-Action Letter stated that IM
would not recommend enforcement action to the
Commission under sections 2(a)(32), 5(a)(1), 17(a),
22(d), and 22(e) of the 1940 Act, or rule 22c–1
under the 1940 Act if actively-managed ETFs
operating in reliance on specified orders (which
include the Trust’s Exemptive Order) invest in
options contracts, futures contracts, or swap
agreements; provided that they comply with the
representations stated in the No-Action Letter, as
noted above.
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
of the No-Action Letter issued by staff
in the Commission’s Division of
Investment Management on December 6,
2012, the Exchange proposes to change
this representation to permit the Fund
to use derivative instruments, as
described below, and makes the
following representations and
statements.12
The Prior Release stated that the Fund
will invest under normal market
circumstances at least 65% of its total
assets in a diversified portfolio of Fixed
Income Instruments of varying
maturities.13 ‘‘Fixed Income
Instruments’’ include bonds, debt
securities and other similar instruments
issued by various U.S. and non-U.S.
public- or private-sector entities.14 The
Exchange proposes to revise this
statement to provide that the Fund will
invest under normal market
circumstances at least 65% of its total
assets in a diversified portfolio of Fixed
Income Instruments of varying
maturities, which may be represented
by derivatives related to Fixed Income
Instruments (‘‘65% policy’’).
The Prior Release stated that the
Fund’s investment would not be used to
enhance leverage. In view of the
Exchange’s proposal to permit the Fund
to use derivative instruments, as
described below, the Fund’s
12 The Adviser represents that the Fund, in
connection with its use of derivative instruments,
will comply with the representations stated in the
No-Action Letter, as noted above. See id.
13 As stated in the Prior Release, the term ‘‘under
normal market circumstances’’ includes, but is not
limited to, the absence of extreme volatility or
trading halts in the fixed income markets or the
financial markets generally; operational issues
causing dissemination of inaccurate market
information; or force majeure type events such as
systems failure, natural or man-made disaster, act
of God, armed conflict, act of terrorism, riot or labor
disruption, or any similar intervening circumstance.
14 As noted in the Prior Release, ‘‘Fixed Income
Instruments,’’ as such term is used generally in the
Registration Statement, include: Debt securities
issued or guaranteed by the U.S. Government, its
agencies or government-sponsored enterprises;
corporate debt securities of U.S. and non-U.S.
issuers, including convertible securities and
corporate commercial paper; mortgage-backed and
other asset-backed securities; inflation-indexed
bonds issued both by governments and
corporations; structured notes, including hybrid or
‘‘indexed’’ securities and event-linked bonds; bank
capital and trust preferred securities; loan
participations and assignments; delayed funding
loans and revolving credit facilities; bank
certificates of deposit, fixed time deposits and
bankers’ acceptances; repurchase agreements on
Fixed Income Instruments and reverse repurchase
agreements on Fixed Income Instruments; debt
securities issued by states or local governments and
their agencies, authorities and other governmentsponsored enterprises; obligations of non-U.S.
governments or their subdivisions, agencies and
government-sponsored enterprises; and obligations
of international agencies or supranational entities.
Securities issued by U.S. Government agencies or
government-sponsored enterprises may not be
guaranteed by the U.S. Treasury.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
44225
investments in derivative instruments
may be used to enhance leverage.
However, as noted in the Prior Release,
the Fund’s investments will not be used
to seek performance that is the multiple
or inverse multiple (e.g., 2Xs and 3Xs)
of the Fund’s broad-based securities
market index.
The Fund’s Use of Derivatives
The Exchange states that, with respect
to the Fund, derivative instruments
primarily will include forwards,
exchange-traded and over-the-counter
(‘‘OTC’’) options contracts, exchangetraded futures contracts, options on
futures contracts, and swap agreements.
Generally, derivatives are financial
contracts whose values depend upon, or
are derived from, the values of an
underlying asset, reference rate, or
index, and may relate to stocks, bonds,
interest rates, currencies or currency
exchange rates, commodities, and
related indexes. The Fund may, but is
not required to, use derivative
instruments for risk management
purposes or as part of its investment
strategies.15
The Exchange represents that the
Fund’s investments in derivative
instruments will be made in accordance
with the 1940 Act and consistent with
the Fund’s investment objective and
policies. As described further below, the
Fund will typically use derivative
instruments as a substitute for taking a
position in the underlying asset or as
part of a strategy designed to reduce
exposure to other risks, such as interest
rate or currency risk. The Fund may also
use derivative instruments to enhance
returns. To limit the potential risk
associated with such transactions, the
Fund will segregate or ‘‘earmark’’ assets
determined to be liquid by PIMCO in
accordance with procedures established
by the Trust’s Board of Trustees and in
accordance with the 1940 Act (or, as
permitted by applicable regulation,
enter into certain offsetting positions) to
cover its obligations under derivative
instruments. These procedures have
been adopted consistent with Section 18
of the 1940 Act and related Commission
guidance. In addition, the Fund will
15 The Exchange represents that the Fund will
seek, where possible, to use counterparties whose
financial status is such that the risk of default is
reduced; however, the risk of losses resulting from
default is still possible. PIMCO’s Counterparty Risk
Committee evaluates the creditworthiness of
counterparties on an ongoing basis. In addition to
information provided by credit agencies, PIMCO
credit analysts evaluate each approved counterparty
using various methods of analysis, including
company visits, earnings updates, the brokerdealer’s reputation, PIMCO’s past experience with
the broker-dealer, market levels for the
counterparty’s debt and equity, the counterparty’s
liquidity, and its share of market participation.
E:\FR\FM\30JYN1.SGM
30JYN1
mstockstill on DSK4VPTVN1PROD with NOTICES
44226
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
include appropriate risk disclosure in
its offering documents, including
leveraging risk. Leveraging risk is the
risk that certain transactions of the
Fund, including the Fund’s use of
derivatives, may give rise to leverage,
causing the Fund to be more volatile
than if it had not been leveraged.16
Because the markets for certain
securities, or the securities themselves,
may be unavailable or cost prohibitive
as compared to derivative instruments,
suitable derivative transactions may be
an efficient alternative for the Fund to
obtain the desired asset exposure.
The Exchange states that the Adviser
believes derivatives can be an
economically attractive substitute for an
underlying physical security that the
Fund would otherwise purchase. For
example, the Fund could purchase
Treasury futures contracts instead of
physical Treasuries or could sell credit
default protection on a corporate bond
instead of buying a physical bond.
Economic benefits include potentially
lower transaction costs or attractive
relative valuation of a derivative versus
a physical bond (e.g., differences in
yields).
The Exchange states the Adviser
further believes that derivatives can be
used as a more liquid means of
adjusting portfolio duration as well as
targeting specific areas of yield curve
exposure, with potentially lower
transaction costs than the underlying
securities (e.g., interest rate swaps may
have lower transaction costs than
physical bonds). Similarly, money
market futures can be used to gain
exposure to short-term interest rates in
order to express views on anticipated
changes in central bank policy rates. In
addition, derivatives can be used to
protect client assets through selectively
hedging downside (or ‘‘tail risks’’) in the
Fund.
The Exchange states that the Fund
also can use derivatives to increase or
decrease credit exposure. Index credit
default swaps (CDX) can be used to gain
exposure to a basket of credit risk by
‘‘selling protection’’ against default or
other credit events, or to hedge broad
market credit risk by ‘‘buying
protection.’’ Single name credit default
swaps (CDS) can be used to allow the
Fund to increase or decrease exposure
to specific issuers, saving investor
capital through lower trading costs. The
Fund can use total return swap
contracts to obtain the total return of a
reference asset or index in exchange for
16 To mitigate leveraging risk, the Adviser will
segregate or ‘‘earmark’’ liquid assets or otherwise
cover the transactions that may give rise to such
risk.
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
paying a financing cost. A total return
swap may be much more efficient than
buying underlying securities of an
index, potentially lowering transaction
costs.
The Exchange states that the Adviser
believes that the use of derivatives will
allow the Fund to selectively add
diversifying sources of return from
selling options. Options purchases and
sales can also be used to hedge specific
exposures in the portfolio, and can
provide access to return streams
available to long-term investors such as
the persistent difference between
implied and realized volatility. Options
strategies can generate income or
improve execution prices (i.e., covered
calls).
Other Investments
In addition to the Fund’s use of
derivatives in connection with the 65%
policy, under the proposal, the Fund
would seek to invest in derivative
instruments not based on Fixed Income
Instruments, consistent with the Fund’s
investment restrictions relating to
exposure to those asset classes.
The Prior Release stated that the Fund
may invest in debt securities and
instruments that are economically tied
to foreign (non-U.S.) countries. The
Prior Release stated further that PIMCO
generally considers an instrument to be
economically tied to a non-U.S. country
if the issuer is a foreign government (or
any political subdivision, agency,
authority or instrumentality of such
government), or if the issuer is
organized under the laws of a non-U.S.
country. In the case of applicable money
market instruments, such instruments
will be considered economically tied to
a non-U.S. country if either the issuer or
the guarantor of such money market
instrument is organized under the laws
of a non-U.S. country.
The Exchange proposes to add to this
representation that, with respect to
derivative instruments, as proposed to
be used, PIMCO generally will consider
such instruments to be economically
tied to non-U.S. countries if the
underlying assets are foreign currencies
(or baskets or indexes of such
currencies), or instruments or securities
that are issued by foreign governments
(or any political subdivision, agency,
authority, or instrumentality of such
governments) or issuers organized under
the laws of a non-U.S. country (or if the
underlying assets are money market
instruments, as applicable, if either the
issuer or the guarantor of such money
market instruments is organized under
the laws of a non-U.S. country).
The Fund’s investments, including
investments in derivative instruments,
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
are subject to all of the restrictions
under the 1940 Act, including
restrictions with respect to illiquid
securities. The Fund may hold up to an
aggregate amount of 15% of its net
assets in illiquid securities (calculated
at the time of investment), including
Rule 144A securities deemed illiquid by
the Adviser, consistent with
Commission guidance. The Fund will
monitor its portfolio liquidity on an
ongoing basis to determine whether, in
light of current circumstances, an
adequate level of liquidity is being
maintained, and will consider taking
appropriate steps in order to maintain
adequate liquidity if, through a change
in values, net assets, or other
circumstances, more than 15% of the
Fund’s net assets are held in illiquid
securities. Illiquid securities include
securities subject to contractual or other
restrictions on resale and other
instruments that lack readily available
markets as determined in accordance
with Commission staff guidance.
The Exchange states that this proposal
would become effective upon (i) the
effectiveness of an amendment to the
Trust’s Registration Statement
disclosing the Fund’s intended use of
derivative instruments and (ii) when
this proposed rule change has become
operative. The Exchange further states
that the Adviser has managed and will
continue to manage the Fund in the
manner described in the Prior Release,
and will not implement the proposed
changes until this proposed rule change
has become operative. In addition, the
Exchange represents that there is no
change to the Fund’s investment
objective and that the Fund will
continue to comply with all initial and
continued listing requirements under
NYSE Arca Equities Rule 8.600. Except
for the changes noted above, the
Exchange represents that all other facts
presented and representations made in
the Prior Release remain unchanged.
Derivatives Valuation Methodology for
Purposes of Determining Net Asset
Value
According to the Exchange, the net
asset value (‘‘NAV’’) of the Fund’s
Shares is determined by dividing the
total value of the Fund’s portfolio
investments and other assets, less any
liabilities, by the total number of Shares
outstanding. Fund Shares are valued as
of the close of regular trading (normally
4:00 p.m. Eastern time (‘‘E.T.’’)) (‘‘NYSE
Close’’) on each day NYSE Arca is open
(‘‘Business Day’’). Information that
becomes known to the Fund or its
agents after the NAV has been
calculated on a particular day will not
generally be used to retroactively adjust
E:\FR\FM\30JYN1.SGM
30JYN1
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
the price of a portfolio asset or the NAV
determined earlier that day. The Fund
reserves the right to change the time its
NAV is calculated if the Fund closes
earlier, or as permitted by the
Commission.
The Exchange states that for purposes
of calculating NAV, portfolio securities
and other assets for which market
quotes are readily available are valued
at market value. Market value is
generally determined on the basis of last
reported sales prices, or if no sales are
reported, based on quotes obtained from
a quotation reporting system,
established market makers, or pricing
services. Domestic and foreign fixed
income securities and non-exchangetraded derivatives will normally be
valued on the basis of quotes obtained
from brokers and dealers or pricing
services using data reflecting the earlier
closing of the principal markets for
those assets. Prices obtained from
independent pricing services use
information provided by market makers
or estimates of market values obtained
from yield data relating to investments
or securities with similar characteristics.
Exchange-traded options, futures, and
options on futures will generally be
valued at the settlement price
determined by the applicable exchange.
Derivatives for which market quotes are
readily available will be valued at
market value. Local closing prices will
be used for all instrument valuation
purposes. For the Fund’s 4:00 p.m. E.T.
futures holdings, estimated prices from
Reuters will be used if any cumulative
futures margin impact is greater than
$0.005 to the NAV due to futures
movement after the fixed income futures
market closes (3:00 p.m. E.T.) and up to
the NYSE Close (generally 4:00 p.m.
E.T.). Swaps traded on exchanges such
as the Chicago Mercantile Exchange or
the Intercontinental Exchange will use
the applicable exchange closing price
where available.
Derivatives Valuation Methodology for
Purposes of Determining Intra-Day
Indicative Value
According to the Exchange, on each
Business Day, before commencement of
trading in Fund Shares on NYSE Arca,
the Fund discloses on its Web site the
identities and quantities of the portfolio
instruments and other assets held by the
Fund that will form the basis for the
Fund’s calculation of NAV at the end of
the Business Day.
In order to provide additional
information regarding the intra-day
value of Shares of the Fund, NYSE Arca
or a market data vendor disseminates
every 15 seconds through the facilities
of the Consolidated Tape Association or
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
other widely disseminated means an
updated Intra-day Indicative Value
(‘‘IIV’’) for the Fund as calculated by an
information provider or market data
vendor.
The Exchange states that a third party
market data provider is currently
calculating the IIV for the Fund. For the
purposes of determining the IIV, the
third party market data provider’s
valuation of derivatives is expected to
be similar to their valuation of all
securities. The third party market data
provider may use market quotes if
available or may fair value securities
against proxies (such as swap or yield
curves).
According to the Exchange, with
respect to specific derivatives:
• Foreign currency derivatives may
be valued intraday using market quotes,
or another proxy as determined to be
appropriate by the third party market
data provider.
• Futures may be valued intraday
using the relevant futures exchange
data, or another proxy as determined to
be appropriate by the third party market
data provider.
• Interest rate swaps may be mapped
to a swap curve and valued intraday
based on changes of the swap curve, or
another proxy as determined to be
appropriate by the third party market
data provider.
• CDX/CDS may be valued using
intraday data from market vendors, or
based on underlying asset price, or
another proxy as determined to be
appropriate by the third party market
data provider.
• Total return swaps may be valued
intraday using the underlying asset
price, or another proxy as determined to
be appropriate by the third party market
data provider.
• Exchange listed options may be
valued intraday using the relevant
exchange data, or another proxy as
determined to be appropriate by the
third party market data provider.
• OTC options may be valued
intraday through option valuation
models (e.g., Black-Scholes) or using
exchange traded options as a proxy, or
another proxy as determined to be
appropriate by the third party market
data provider.
Disclosed Portfolio
The Exchange states that the Fund’s
disclosure of derivative positions in the
Disclosed Portfolio will include
information that market participants can
use to value these positions intraday.
On a daily basis, the Fund will disclose
on the Fund’s Web site the following
information regarding each portfolio
holding, as applicable to the type of
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
44227
holding: Ticker symbol, CUSIP number
or other identifier, if any; a description
of the holding (including the type of
holding, such as the type of swap); the
identity of the security, commodity,
index or other asset or instrument
underlying the holding, if any; for
options, the option strike price; quantity
held (as measured by, for example, par
value, notional value or number of
shares, contracts or units); maturity
date, if any; coupon rate, if any;
effective date, if any; market value of the
holding; and the percentage weighting
of the holding in the Fund’s portfolio.
Impact on Arbitrage Mechanism
The Exchange states that the Adviser
believes there will be minimal, if any,
impact to the arbitrage mechanism as a
result of the use of derivatives. Market
makers and participants should be able
to value derivatives as long as the
positions are disclosed with relevant
information. The Exchange states that
the Adviser believes that the price at
which Shares trade will continue to be
disciplined by arbitrage opportunities
created by the ability to purchase or
redeem creation Shares at their NAV,
which should ensure that Shares will
not trade at a material discount or
premium in relation to their NAV.
The Exchange states that, according to
the Adviser, there will not be any
significant impacts to the settlement or
operational aspects of the Fund’s
arbitrage mechanism due to the use of
derivatives. Because derivatives
generally are not eligible for in-kind
transfer, they will typically be
substituted with a ‘‘cash in lieu’’
amount when the Fund processes
purchases or redemptions of creation
units in-kind.
Surveillance
The Exchange represents that trading
in the Shares will be subject to the
existing trading surveillances,
administered by the Financial Industry
Regulatory Authority (‘‘FINRA’’) on
behalf of the Exchange, which are
designed to detect violations of
Exchange rules and applicable federal
securities laws.17 The Exchange
represents that these procedures are
adequate to properly monitor Exchange
trading of the Shares in all trading
sessions and to deter and detect
violations of Exchange rules and
applicable federal securities laws.
The surveillances referred to above
generally focus on detecting securities
trading outside their normal patterns,
17 FINRA surveils trading on the Exchange
pursuant to a regulatory services agreement. The
Exchange is responsible for FINRA’s performance
under this regulatory services agreement.
E:\FR\FM\30JYN1.SGM
30JYN1
44228
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
which could be indicative of
manipulative or other violative activity.
When such situations are detected,
surveillance analysis follows and
investigations are opened, where
appropriate, to review the behavior of
all relevant parties for all relevant
trading violations.
FINRA, on behalf of the Exchange,
will communicate as needed regarding
trading in the Shares, exchange traded
options, futures, and options on futures
with other markets or other entities that
are members of the Intermarket
Surveillance Group (‘‘ISG’’), and FINRA
may obtain trading information
regarding trading in the Shares,
exchange traded options, futures, and
options on futures from such markets or
entities. In addition, the Exchange may
obtain information regarding trading in
the Shares, exchange traded options,
futures, and options on futures from
markets or other entities that are
members of ISG or with which the
Exchange has in place a comprehensive
surveillance sharing agreement.18 In
addition, FINRA, on behalf of the
Exchange, is able to access, as needed,
trade information for certain fixed
income securities held by the Fund
reported to FINRA’s Trade Reporting
and Compliance Engine (‘‘TRACE’’).
The Exchange also states that it has a
general policy prohibiting the
distribution of material, non-public
information by its employees.
Additional information regarding the
Trust, the Fund, and the Shares,
including investment strategies, risks,
NAV calculation, creation and
redemption procedures, fees, portfolio
holdings, disclosure policies,
distributions and taxes is included in
the Prior Release, Notice, and the
Registration Statement, as applicable.19
mstockstill on DSK4VPTVN1PROD with NOTICES
III. Discussion and Commission’s
Findings
The Commission has carefully
reviewed the proposed rule change and
finds that it is consistent with the
requirements of Section 6 of the Act 20
and the rules and regulations
thereunder applicable to a national
securities exchange.21 In particular, the
Commission finds that the proposal is
consistent with Section 6(b)(5) of the
18 For a list of the current members of ISG, see
www.isgportal.org. The Exchange notes that not all
components of the Disclosed Portfolio for the Fund
may trade on markets that are members of ISG or
with which the Exchange has in place a
comprehensive surveillance sharing agreement.
19 See supra notes 9, 3, and 10.
20 15 U.S.C. 78f.
21 In approving this proposed rule change, the
Commission has considered the proposed rule’s
impact on efficiency, competition, and capital
formation. See 15 U.S.C. 78c(f).
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
Act,22 which requires, among other
things, that the Exchange’s rules be
designed to prevent fraudulent and
manipulative acts and practices, to
promote just and equitable principles of
trade, to foster cooperation and
coordination with persons engaged in
facilitating transactions in securities, to
remove impediments to, and perfect the
mechanism of, a free and open market
and a national market system, and, in
general, to protect investors and the
public interest. The Commission notes
that the Fund and the Shares must
comply with the requirements of NYSE
Arca Equities Rule 8.600 to continue to
be listed and traded on the Exchange.
The Commission notes that, with
respect to its proposed investments in
derivatives, the Fund will seek, where
possible, to use counterparties whose
financial status is such that the risk of
default is reduced. The Exchange states
that PIMCO’s Counterparty Risk
Committee will evaluate the
creditworthiness of counterparties on an
ongoing basis. In addition to
information provided by credit agencies,
PIMCO credit analysts will evaluate
each approved counterparty using
various methods of analysis, including
company visits, earnings updates, the
broker-dealer’s reputation, PIMCO’s past
experience with the broker-dealer,
market levels for the counterparty’s debt
and equity, the counterparty’s liquidity,
and its share of market participation.
In addition, according to the
Exchange, the proposed investments in
derivative instruments will be made in
accordance with the 1940 Act and
consistent with the Fund’s investment
objective and policies. To further limit
the potential risk associated with such
transactions, the Fund will segregate or
‘‘earmark’’ assets determined to be
liquid by PIMCO in accordance with
procedures established by the Trust’s
Board of Trustees and in accordance
with the 1940 Act (or, as permitted by
applicable regulation, enter into certain
offsetting positions) to cover its
obligations under the proposed
derivative instruments. The Exchange
represents that these procedures have
been adopted consistent with Section 18
of the 1940 Act and related Commission
guidance. In addition, with respect to
the proposed investments in derivative
instruments, the Exchange states that
appropriate risk disclosures will be
provided in the Fund’s offering
documents, including leveraging risk.
The Exchange further represents that the
Fund’s investments, including the
proposed investments in derivative
instruments, are subject to all of the
PO 00000
22 15
U.S.C. 78f(b)(5).
Frm 00077
Fmt 4703
Sfmt 4703
restrictions under the 1940 Act,
including restrictions with respect to
illiquid securities.
Further, the Commission notes that
the Fund’s disclosure of derivative
positions in the Disclosed Portfolio will
include information that market
participants can use to value these
positions intraday. This information
will include, as applicable to the type of
holding: Ticker symbol, CUSIP number
or other identifier, if any; a description
of the holding (including the type of
holding, such as the type of swap); the
identity of the security, commodity,
index or other asset or instrument
underlying the holding, if any; for
options, the option strike price; quantity
held (as measured by, for example, par
value, notional value or number of
shares, contracts or units); maturity
date, if any; coupon rate, if any;
effective date, if any; market value of the
holding; and the percentage weighting
of the holding in the Fund’s portfolio.
The Exchange states that there will be
minimal, if any, impact to the arbitrage
mechanism as a result of the use of
derivatives. Market makers and
participants should be able to value
derivatives as long as the positions are
disclosed with relevant information.
The Exchange notes that the price at
which Shares trade will continue to be
disciplined by arbitrage opportunities
created by the ability to purchase or
redeem creation Shares at their NAV,
which should ensure that Shares will
not trade at a material discount or
premium in relation to their NAV. In
addition, the Exchange notes that there
will not be any significant impacts to
the settlement or operational aspects of
the Fund’s arbitrage mechanism due to
the use of derivatives.
In support of this proposal, the
Exchange has made additional
representations, including:
(1) The Adviser has managed and will
continue to manage the Fund in the
manner described in the Prior Release.
(2) There is no change to the Fund’s
investment objective.
(3) The Fund will continue to comply
with all initial and continued listing
requirements under NYSE Arca Equities
Rule 8.600.
(4) FINRA, on behalf of the Exchange,
will communicate as needed regarding
trading in the Shares, exchange traded
options, futures, and options on futures
with other markets or other entities that
are members of the ISG, and FINRA may
obtain trading information regarding
trading in the Shares, exchange traded
options, futures, and options on futures
from such markets or entities. In
addition, the Exchange may obtain
information regarding trading in the
E:\FR\FM\30JYN1.SGM
30JYN1
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
Shares, exchange traded options,
futures, and options on futures from
markets or other entities that are
members of ISG or with which the
Exchange has in place a comprehensive
surveillance sharing agreement. In
addition, FINRA, on behalf of the
Exchange, is able to access, as needed,
trade information for certain fixed
income securities held by the Fund
reported to FINRA’s TRACE.
(5) The Fund will comply with the
representations as prescribed in the NoAction Letter.
(6) Except for the proposed changes,
all other facts presented and
representations made in the Prior
Release remain unchanged.
This approval order is based on the
Exchange’s representations and
description of the Fund, including those
set forth above and in the Notice. For
the foregoing reasons, the Commission
finds that the proposed rule change, as
modified by Amendment No. 2, is
consistent with Section 6(b)(5) of the
Act 23 and the rules and regulations
thereunder applicable to a national
securities exchange.
IV. Conclusion
It is therefore ordered, pursuant to
Section 19(b)(2) of the Act,24 that the
proposed rule change (SR–NYSEArca–
2013–122) as modified by Amendment
No. 2 thereto be, and it hereby is,
approved.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.25
Kevin M. O’Neill,
Deputy Secretary.
[FR Doc. 2014–17880 Filed 7–29–14; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–72668; File No. SR–CBOE–
2014–048]
Self-Regulatory Organizations;
Chicago Board Options Exchange,
Incorporated; Order Granting Approval
of a Proposed Rule Change Relating to
the Give Up of a Clearing Trading
Permit Holder
mstockstill on DSK4VPTVN1PROD with NOTICES
July 24, 2014.
I. Introduction
On May 23, 2014, Chicago Board
Options Exchange, Incorporated
(‘‘CBOE’’ or the ‘‘Exchange’’) filed with
the Securities and Exchange
23 15
U.S.C. 78f(b)(5).
U.S.C. 78s(b)(2).
25 17 CFR 200.30–3(a)(12).
24 15
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
Commission (‘‘Commission’’), pursuant
to Section 19(b)(1) of the Securities
Exchange Act of 1934 (‘‘Act’’),1 and
Rule 19b–4 thereunder,2 a proposed rule
change relating to the ‘‘give up’’ process,
the process by which a Trading Permit
Holder (‘‘TPH’’) ‘‘gives up’’ or selects
and indicates the Clearing Trading
Permit Holder (‘‘CTPH’’) responsible for
the clearance of an Exchange
transaction. The proposed rule change
was published for comment in the
Federal Register on June 11, 2014.3 The
Commission received no comment
letters on the proposal. This order
approves the proposed rule change.
II. Description of the Proposal
A. Background
CBOE proposes to amend Rules 6.21
and 6.50 that govern the give up of a
CTPH by a TPH on Exchange
transactions. In order to enter
transactions on the Exchange, a TPH
must either be a CTPH or have a CTPH
agree to accept financial responsibility
for the TPH’s transactions. Current
CBOE Rule 6.21 provides that for each
transaction in which a TPH participates,
the TPH must give up the name of the
CTPH (the ‘‘give up’’) through which the
transaction will be cleared. CBOE Rule
6.50 further provides that every CTPH
will be responsible for the clearance of
Exchange transactions of each TPH that
gives up the CTPH’s name pursuant to
a letter of authorization, letter of
guarantee, or other authorization given
by the CTPH to the executing TPH.4
CBOE proposes to amend Rules 6.21
and 6.50 to address the give up process,
including procedures governing that
process, in greater detail.
B. Designated Give Ups and Guarantors
CBOE proposes to amend Rule 6.21 to
provide that a TPH that is not a market
maker may only give up (i) a CTPH that
has previously been identified and
processed by the Exchange as a
‘‘designated give up’’ for that TPH, or
(ii) a guarantor of the TPH. The
Exchange proposes to introduce and
define the term ‘‘designated give up’’ as
a CTPH that a TPH (other than a market
maker) identifies in advance to the
Exchange, in writing, as a CTPH that the
TPH would like the ability to give up on
its trades.5 A TPH will be required to
identify to CBOE any designated give
ups in advance of giving up any CTPH
U.S.C. 78s(b)(1).
CFR 240.19b–4.
3 See Securities Exchange Act Release No. 72325
(June 5, 2014), 79 FR 33614 (June 11, 2014)
(‘‘Notice’’).
4 See Notice, supra note 3, at 33614.
5 See proposed Rule 6.21(b)(i).
PO 00000
44229
that is not a guarantor for the TPH. The
Exchange has proposed a standardized
form (‘‘Notification Form’’) that a TPH
will be required to submit to the
Exchange’s Registration Services
Department in order to identify its
designated give ups. If a TPH no longer
wants the ability to give up a particular
designated give up, the TPH must notify
the Exchange in writing by submitting a
Notification Form. CBOE proposes to
allow a TPH to submit a Notification
Form identifying any CTPH as a
designated give up and does not
propose any minimum or maximum
number of designated give ups that a
TPH may identify.6
The Exchange will notify a CTPH, in
writing and as soon as practicable, of
each TPH that has identified the CTPH
as one of its designated give ups. In its
proposal, CBOE noted that it will
disregard any instructions from a CTPH
not to permit a particular TPH to
designate the CTPH as a designated give
up and will not perform any subjective
evaluation of a TPH’s list of proposed
designated give ups.7 Rather, the
Exchange will only ensure that the
CTPHs that a TPH identifies on the
Notification Form as designated give
ups are current CBOE CTPHs and will
review the Notification Form for
completeness and accuracy.8
CBOE proposes to define the term
‘‘guarantor’’ for purposes of proposed
Rule 6.21 as a CTPH that has issued a
letter of guarantee or a letter of
authorization for the executing TPH
under the rules of the Exchange that are
in effect at the time of the execution of
the trade.9 An executing TPH may give
up its guarantor without identifying the
guarantor as a designated give up (i.e.,
the guarantor accepts clearing
responsibility for all trades of its
guarantee TPH pursuant to its role as
the default CTPH for that TPH, unless
the TPH indicates an alternate CTPH to
be the designed give up on a particular
trade), and the TPH therefore would not
need to submit a Notification Form to
the Exchange before indicating its
guarantor as a designated give up.
Because CBOE Rule 8.5 requires that a
letter of guarantee be issued and filed
with the Exchange by each CTPH
through which a market maker desires
to clear transactions, the Exchange
proposes that a TPH that is a market
1 15
2 17
Frm 00078
Fmt 4703
Sfmt 4703
6 See
Notice, supra note 3, at 33614.
id. The ability of a CTPH to reject a trade
on which it was indicated as the designated give up
is discussed below.
8 See id.
9 See proposed Rule 6.21(b)(ii).
7 See
E:\FR\FM\30JYN1.SGM
30JYN1
Agencies
[Federal Register Volume 79, Number 146 (Wednesday, July 30, 2014)]
[Notices]
[Pages 44224-44229]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17880]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[Release No. 34-72666; File No. SR-NYSEArca-2013-122]
Self-Regulatory Organizations; NYSE Arca, Inc.; Order Granting
Approval of Proposed Rule Change as Modified by Amendment No. 2 Thereto
Relating to the Use of Derivative Instruments by PIMCO Total Return
Exchange Traded Fund
July 24, 2014.
I. Introduction
On November 6, 2013, NYSE Arca, Inc. (``Exchange'' or ``NYSE
Arca'') filed with the Securities and Exchange Commission
(``Commission''), pursuant to Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder,\2\ a
proposed rule change to amend the description of the means of achieving
the investment objective applicable to the PIMCO Total Return Exchange
Traded Fund (``Fund'') relating to its use of derivative instruments.
The proposed rule change was published for comment in the Federal
Register on November 26, 2013.\3\ On January 9, 2014, the Commission
designated a longer period within which to approve the proposed rule
change, disapprove the proposed rule change, or institute proceedings
to determine whether to disapprove the proposed rule change.\4\ On
February 24, 2014, the Commission instituted proceedings to determine
whether to approve or disapprove the proposed rule change.\5\ On April
15, 2014, the Exchange submitted Amendments No. 1 and 2 to the proposed
rule change.\6\ On May 21, 2014, pursuant to Section 19(b)(2) of the
Act,\7\ the Commission designated a longer period within which to issue
an order approving or disapproving the proposed rule change.\8\ The
Commission received no comments
[[Page 44225]]
on the proposal. This order grants approval of the proposed rule
change.
---------------------------------------------------------------------------
\1\ 15 U.S.C. 78s(b)(1).
\2\ 17 CFR 240.19b-4.
\3\ See Securities Exchange Act Release No. 70905 (November 20,
2013), 78 FR 70610 (``Notice'').
\4\ See Securities Exchange Act Release No. 71271 (January 9,
2014), 79 FR 2736 (January 15, 2014). The Commission determined that
it was appropriate to designate a longer period within which to take
action on the proposed rule change so that it has sufficient time to
consider the proposed rule change. Accordingly, the Commission
designated February 24, 2014 as the date by which it should approve,
disapprove, or institute proceedings to determine whether to
disapprove the proposed rule change.
\5\ See Securities Exchange Act Release No. 71606, 79 FR 11486
(February 28, 2014).
\6\ The Exchange submitted and subsequently withdrew Amendment
No. 1 to the proposed rule change. In Amendment No. 2, the Exchange
provided additional details describing how the contents of the
portfolio composition of the Fund would be disclosed on a daily
basis. Specifically, the Fund will disclose on the Fund's Web site
the following information regarding each portfolio holding, as
applicable to the type of holding: ticker symbol, CUSIP number or
other identifier, if any; a description of the holding (including
the type of holding, such as the type of swap); the identity of the
security, commodity, index or other asset or instrument underlying
the holding, if any; for options, the option strike price; quantity
held (as measured by, for example, par value, notional value or
number of shares, contracts or units); maturity date, if any; coupon
rate, if any; effective date, if any; market value of the holding;
and the percentage weighting of the holding in the Fund's portfolio.
It also confirms that all other facts and representations made in
the Prior Release remain unchanged. See infra, note 9. Amendment No.
2 provides clarification to the proposed rule change, and because it
does not materially affect the substance of the proposed rule
change, Amendment No. 2 does not require notice and comment.
\7\ 15 U.S.C. 78s(b)(1).
\8\ See Securities Exchange Act Release No. 72216, 79 FR 30680
(May 28, 2014).
---------------------------------------------------------------------------
II. Description of the Proposed Rule Change
The Commission previously approved the listing and trading of
shares (``Shares'') of the Fund under NYSE Arca Equities Rule 8.600,
which governs the listing and trading of Managed Fund Shares on the
Exchange.\9\ The Shares are offered by PIMCO ETF Trust (``Trust''), a
statutory trust organized under the laws of the State of Delaware and
registered with the Commission as an open-end management investment
company.\10\ The investment manager to the Fund is Pacific Investment
Management Company LLC (``PIMCO'' or ``Adviser'').
---------------------------------------------------------------------------
\9\ See Securities Exchange Act Release No. 66321 (February 3,
2012), 77 FR 6850 (February 9, 2012) (SR-NYSEArca-2011-95) (``Prior
Order''). See also Securities Exchange Act Release No. 65988
(December 16, 2011), 76 FR 79741 (December 22, 2011) (SR-NYSEArca-
2011-95) (``Prior Notice,'' and together with the Prior Order,
collectively, ``Prior Release'').
\10\ The Exchange represents that the Trust is registered under
the Investment Company Act of 1940 (``1940 Act''). On October 29,
2012 the Trust filed with the Commission the most recent post-
effective amendment to its registration statement under the
Securities Act of 1933 and under the 1940 Act relating to the Fund
(File Nos. 333-155395 and 811-22250) (``Registration Statement'').
The Exchange further represents that the Trust has obtained certain
exemptive relief under the 1940 Act. See Investment Company Act
Release No. 28993 (November 10, 2009) (File No. 812-13571)
(``Exemptive Order'').
---------------------------------------------------------------------------
In the Prior Release, the Exchange stated that, consistent with the
Trust's Exemptive Order, the Fund would not invest in options
contracts, futures contracts, or swap agreements.\11\ In view of the
No-Action Letter issued by staff in the Commission's Division of
Investment Management on December 6, 2012, the Exchange proposes to
change this representation to permit the Fund to use derivative
instruments, as described below, and makes the following
representations and statements.\12\
---------------------------------------------------------------------------
\11\ On December 6, 2012, the staff of the Commission's Division
of Investment Management (``IM'') issued a no-action letter (``No-
Action Letter'') relating to the use of derivatives by actively-
managed exchange traded funds (``ETFs''). See No-Action Letter dated
December 6, 2012 from Elizabeth G. Osterman, Associate Director,
Office of Exemptive Applications, IM. The No-Action Letter stated
that IM staff would no longer defer consideration of exemptive
requests under the 1940 Act relating to actively-managed ETFs that
make use of derivatives provided that they include representations
to address some of the concerns expressed in the Commission's March
2010 press release. These representations are: (i) That the ETF's
board periodically will review and approve the ETF's use of
derivatives and how the ETF's investment adviser assesses and
manages risk with respect to the ETF's use of derivatives; and (ii)
that the ETF's disclosure of its use of derivatives in its offering
documents and periodic reports is consistent with relevant
Commission and staff guidance. The No-Action Letter stated that IM
would not recommend enforcement action to the Commission under
sections 2(a)(32), 5(a)(1), 17(a), 22(d), and 22(e) of the 1940 Act,
or rule 22c-1 under the 1940 Act if actively-managed ETFs operating
in reliance on specified orders (which include the Trust's Exemptive
Order) invest in options contracts, futures contracts, or swap
agreements; provided that they comply with the representations
stated in the No-Action Letter, as noted above.
\12\ The Adviser represents that the Fund, in connection with
its use of derivative instruments, will comply with the
representations stated in the No-Action Letter, as noted above. See
id.
---------------------------------------------------------------------------
The Prior Release stated that the Fund will invest under normal
market circumstances at least 65% of its total assets in a diversified
portfolio of Fixed Income Instruments of varying maturities.\13\
``Fixed Income Instruments'' include bonds, debt securities and other
similar instruments issued by various U.S. and non-U.S. public- or
private-sector entities.\14\ The Exchange proposes to revise this
statement to provide that the Fund will invest under normal market
circumstances at least 65% of its total assets in a diversified
portfolio of Fixed Income Instruments of varying maturities, which may
be represented by derivatives related to Fixed Income Instruments
(``65% policy'').
---------------------------------------------------------------------------
\13\ As stated in the Prior Release, the term ``under normal
market circumstances'' includes, but is not limited to, the absence
of extreme volatility or trading halts in the fixed income markets
or the financial markets generally; operational issues causing
dissemination of inaccurate market information; or force majeure
type events such as systems failure, natural or man-made disaster,
act of God, armed conflict, act of terrorism, riot or labor
disruption, or any similar intervening circumstance.
\14\ As noted in the Prior Release, ``Fixed Income
Instruments,'' as such term is used generally in the Registration
Statement, include: Debt securities issued or guaranteed by the U.S.
Government, its agencies or government-sponsored enterprises;
corporate debt securities of U.S. and non-U.S. issuers, including
convertible securities and corporate commercial paper; mortgage-
backed and other asset-backed securities; inflation-indexed bonds
issued both by governments and corporations; structured notes,
including hybrid or ``indexed'' securities and event-linked bonds;
bank capital and trust preferred securities; loan participations and
assignments; delayed funding loans and revolving credit facilities;
bank certificates of deposit, fixed time deposits and bankers'
acceptances; repurchase agreements on Fixed Income Instruments and
reverse repurchase agreements on Fixed Income Instruments; debt
securities issued by states or local governments and their agencies,
authorities and other government-sponsored enterprises; obligations
of non-U.S. governments or their subdivisions, agencies and
government-sponsored enterprises; and obligations of international
agencies or supranational entities. Securities issued by U.S.
Government agencies or government-sponsored enterprises may not be
guaranteed by the U.S. Treasury.
---------------------------------------------------------------------------
The Prior Release stated that the Fund's investment would not be
used to enhance leverage. In view of the Exchange's proposal to permit
the Fund to use derivative instruments, as described below, the Fund's
investments in derivative instruments may be used to enhance leverage.
However, as noted in the Prior Release, the Fund's investments will not
be used to seek performance that is the multiple or inverse multiple
(e.g., 2Xs and 3Xs) of the Fund's broad-based securities market index.
The Fund's Use of Derivatives
The Exchange states that, with respect to the Fund, derivative
instruments primarily will include forwards, exchange-traded and over-
the-counter (``OTC'') options contracts, exchange-traded futures
contracts, options on futures contracts, and swap agreements.
Generally, derivatives are financial contracts whose values depend
upon, or are derived from, the values of an underlying asset, reference
rate, or index, and may relate to stocks, bonds, interest rates,
currencies or currency exchange rates, commodities, and related
indexes. The Fund may, but is not required to, use derivative
instruments for risk management purposes or as part of its investment
strategies.\15\
---------------------------------------------------------------------------
\15\ The Exchange represents that the Fund will seek, where
possible, to use counterparties whose financial status is such that
the risk of default is reduced; however, the risk of losses
resulting from default is still possible. PIMCO's Counterparty Risk
Committee evaluates the creditworthiness of counterparties on an
ongoing basis. In addition to information provided by credit
agencies, PIMCO credit analysts evaluate each approved counterparty
using various methods of analysis, including company visits,
earnings updates, the broker-dealer's reputation, PIMCO's past
experience with the broker-dealer, market levels for the
counterparty's debt and equity, the counterparty's liquidity, and
its share of market participation.
---------------------------------------------------------------------------
The Exchange represents that the Fund's investments in derivative
instruments will be made in accordance with the 1940 Act and consistent
with the Fund's investment objective and policies. As described further
below, the Fund will typically use derivative instruments as a
substitute for taking a position in the underlying asset or as part of
a strategy designed to reduce exposure to other risks, such as interest
rate or currency risk. The Fund may also use derivative instruments to
enhance returns. To limit the potential risk associated with such
transactions, the Fund will segregate or ``earmark'' assets determined
to be liquid by PIMCO in accordance with procedures established by the
Trust's Board of Trustees and in accordance with the 1940 Act (or, as
permitted by applicable regulation, enter into certain offsetting
positions) to cover its obligations under derivative instruments. These
procedures have been adopted consistent with Section 18 of the 1940 Act
and related Commission guidance. In addition, the Fund will
[[Page 44226]]
include appropriate risk disclosure in its offering documents,
including leveraging risk. Leveraging risk is the risk that certain
transactions of the Fund, including the Fund's use of derivatives, may
give rise to leverage, causing the Fund to be more volatile than if it
had not been leveraged.\16\ Because the markets for certain securities,
or the securities themselves, may be unavailable or cost prohibitive as
compared to derivative instruments, suitable derivative transactions
may be an efficient alternative for the Fund to obtain the desired
asset exposure.
---------------------------------------------------------------------------
\16\ To mitigate leveraging risk, the Adviser will segregate or
``earmark'' liquid assets or otherwise cover the transactions that
may give rise to such risk.
---------------------------------------------------------------------------
The Exchange states that the Adviser believes derivatives can be an
economically attractive substitute for an underlying physical security
that the Fund would otherwise purchase. For example, the Fund could
purchase Treasury futures contracts instead of physical Treasuries or
could sell credit default protection on a corporate bond instead of
buying a physical bond. Economic benefits include potentially lower
transaction costs or attractive relative valuation of a derivative
versus a physical bond (e.g., differences in yields).
The Exchange states the Adviser further believes that derivatives
can be used as a more liquid means of adjusting portfolio duration as
well as targeting specific areas of yield curve exposure, with
potentially lower transaction costs than the underlying securities
(e.g., interest rate swaps may have lower transaction costs than
physical bonds). Similarly, money market futures can be used to gain
exposure to short-term interest rates in order to express views on
anticipated changes in central bank policy rates. In addition,
derivatives can be used to protect client assets through selectively
hedging downside (or ``tail risks'') in the Fund.
The Exchange states that the Fund also can use derivatives to
increase or decrease credit exposure. Index credit default swaps (CDX)
can be used to gain exposure to a basket of credit risk by ``selling
protection'' against default or other credit events, or to hedge broad
market credit risk by ``buying protection.'' Single name credit default
swaps (CDS) can be used to allow the Fund to increase or decrease
exposure to specific issuers, saving investor capital through lower
trading costs. The Fund can use total return swap contracts to obtain
the total return of a reference asset or index in exchange for paying a
financing cost. A total return swap may be much more efficient than
buying underlying securities of an index, potentially lowering
transaction costs.
The Exchange states that the Adviser believes that the use of
derivatives will allow the Fund to selectively add diversifying sources
of return from selling options. Options purchases and sales can also be
used to hedge specific exposures in the portfolio, and can provide
access to return streams available to long-term investors such as the
persistent difference between implied and realized volatility. Options
strategies can generate income or improve execution prices (i.e.,
covered calls).
Other Investments
In addition to the Fund's use of derivatives in connection with the
65% policy, under the proposal, the Fund would seek to invest in
derivative instruments not based on Fixed Income Instruments,
consistent with the Fund's investment restrictions relating to exposure
to those asset classes.
The Prior Release stated that the Fund may invest in debt
securities and instruments that are economically tied to foreign (non-
U.S.) countries. The Prior Release stated further that PIMCO generally
considers an instrument to be economically tied to a non-U.S. country
if the issuer is a foreign government (or any political subdivision,
agency, authority or instrumentality of such government), or if the
issuer is organized under the laws of a non-U.S. country. In the case
of applicable money market instruments, such instruments will be
considered economically tied to a non-U.S. country if either the issuer
or the guarantor of such money market instrument is organized under the
laws of a non-U.S. country.
The Exchange proposes to add to this representation that, with
respect to derivative instruments, as proposed to be used, PIMCO
generally will consider such instruments to be economically tied to
non-U.S. countries if the underlying assets are foreign currencies (or
baskets or indexes of such currencies), or instruments or securities
that are issued by foreign governments (or any political subdivision,
agency, authority, or instrumentality of such governments) or issuers
organized under the laws of a non-U.S. country (or if the underlying
assets are money market instruments, as applicable, if either the
issuer or the guarantor of such money market instruments is organized
under the laws of a non-U.S. country).
The Fund's investments, including investments in derivative
instruments, are subject to all of the restrictions under the 1940 Act,
including restrictions with respect to illiquid securities. The Fund
may hold up to an aggregate amount of 15% of its net assets in illiquid
securities (calculated at the time of investment), including Rule 144A
securities deemed illiquid by the Adviser, consistent with Commission
guidance. The Fund will monitor its portfolio liquidity on an ongoing
basis to determine whether, in light of current circumstances, an
adequate level of liquidity is being maintained, and will consider
taking appropriate steps in order to maintain adequate liquidity if,
through a change in values, net assets, or other circumstances, more
than 15% of the Fund's net assets are held in illiquid securities.
Illiquid securities include securities subject to contractual or other
restrictions on resale and other instruments that lack readily
available markets as determined in accordance with Commission staff
guidance.
The Exchange states that this proposal would become effective upon
(i) the effectiveness of an amendment to the Trust's Registration
Statement disclosing the Fund's intended use of derivative instruments
and (ii) when this proposed rule change has become operative. The
Exchange further states that the Adviser has managed and will continue
to manage the Fund in the manner described in the Prior Release, and
will not implement the proposed changes until this proposed rule change
has become operative. In addition, the Exchange represents that there
is no change to the Fund's investment objective and that the Fund will
continue to comply with all initial and continued listing requirements
under NYSE Arca Equities Rule 8.600. Except for the changes noted
above, the Exchange represents that all other facts presented and
representations made in the Prior Release remain unchanged.
Derivatives Valuation Methodology for Purposes of Determining Net Asset
Value
According to the Exchange, the net asset value (``NAV'') of the
Fund's Shares is determined by dividing the total value of the Fund's
portfolio investments and other assets, less any liabilities, by the
total number of Shares outstanding. Fund Shares are valued as of the
close of regular trading (normally 4:00 p.m. Eastern time (``E.T.''))
(``NYSE Close'') on each day NYSE Arca is open (``Business Day'').
Information that becomes known to the Fund or its agents after the NAV
has been calculated on a particular day will not generally be used to
retroactively adjust
[[Page 44227]]
the price of a portfolio asset or the NAV determined earlier that day.
The Fund reserves the right to change the time its NAV is calculated if
the Fund closes earlier, or as permitted by the Commission.
The Exchange states that for purposes of calculating NAV, portfolio
securities and other assets for which market quotes are readily
available are valued at market value. Market value is generally
determined on the basis of last reported sales prices, or if no sales
are reported, based on quotes obtained from a quotation reporting
system, established market makers, or pricing services. Domestic and
foreign fixed income securities and non-exchange-traded derivatives
will normally be valued on the basis of quotes obtained from brokers
and dealers or pricing services using data reflecting the earlier
closing of the principal markets for those assets. Prices obtained from
independent pricing services use information provided by market makers
or estimates of market values obtained from yield data relating to
investments or securities with similar characteristics. Exchange-traded
options, futures, and options on futures will generally be valued at
the settlement price determined by the applicable exchange. Derivatives
for which market quotes are readily available will be valued at market
value. Local closing prices will be used for all instrument valuation
purposes. For the Fund's 4:00 p.m. E.T. futures holdings, estimated
prices from Reuters will be used if any cumulative futures margin
impact is greater than $0.005 to the NAV due to futures movement after
the fixed income futures market closes (3:00 p.m. E.T.) and up to the
NYSE Close (generally 4:00 p.m. E.T.). Swaps traded on exchanges such
as the Chicago Mercantile Exchange or the Intercontinental Exchange
will use the applicable exchange closing price where available.
Derivatives Valuation Methodology for Purposes of Determining Intra-Day
Indicative Value
According to the Exchange, on each Business Day, before
commencement of trading in Fund Shares on NYSE Arca, the Fund discloses
on its Web site the identities and quantities of the portfolio
instruments and other assets held by the Fund that will form the basis
for the Fund's calculation of NAV at the end of the Business Day.
In order to provide additional information regarding the intra-day
value of Shares of the Fund, NYSE Arca or a market data vendor
disseminates every 15 seconds through the facilities of the
Consolidated Tape Association or other widely disseminated means an
updated Intra-day Indicative Value (``IIV'') for the Fund as calculated
by an information provider or market data vendor.
The Exchange states that a third party market data provider is
currently calculating the IIV for the Fund. For the purposes of
determining the IIV, the third party market data provider's valuation
of derivatives is expected to be similar to their valuation of all
securities. The third party market data provider may use market quotes
if available or may fair value securities against proxies (such as swap
or yield curves).
According to the Exchange, with respect to specific derivatives:
Foreign currency derivatives may be valued intraday using
market quotes, or another proxy as determined to be appropriate by the
third party market data provider.
Futures may be valued intraday using the relevant futures
exchange data, or another proxy as determined to be appropriate by the
third party market data provider.
Interest rate swaps may be mapped to a swap curve and
valued intraday based on changes of the swap curve, or another proxy as
determined to be appropriate by the third party market data provider.
CDX/CDS may be valued using intraday data from market
vendors, or based on underlying asset price, or another proxy as
determined to be appropriate by the third party market data provider.
Total return swaps may be valued intraday using the
underlying asset price, or another proxy as determined to be
appropriate by the third party market data provider.
Exchange listed options may be valued intraday using the
relevant exchange data, or another proxy as determined to be
appropriate by the third party market data provider.
OTC options may be valued intraday through option
valuation models (e.g., Black-Scholes) or using exchange traded options
as a proxy, or another proxy as determined to be appropriate by the
third party market data provider.
Disclosed Portfolio
The Exchange states that the Fund's disclosure of derivative
positions in the Disclosed Portfolio will include information that
market participants can use to value these positions intraday. On a
daily basis, the Fund will disclose on the Fund's Web site the
following information regarding each portfolio holding, as applicable
to the type of holding: Ticker symbol, CUSIP number or other
identifier, if any; a description of the holding (including the type of
holding, such as the type of swap); the identity of the security,
commodity, index or other asset or instrument underlying the holding,
if any; for options, the option strike price; quantity held (as
measured by, for example, par value, notional value or number of
shares, contracts or units); maturity date, if any; coupon rate, if
any; effective date, if any; market value of the holding; and the
percentage weighting of the holding in the Fund's portfolio.
Impact on Arbitrage Mechanism
The Exchange states that the Adviser believes there will be
minimal, if any, impact to the arbitrage mechanism as a result of the
use of derivatives. Market makers and participants should be able to
value derivatives as long as the positions are disclosed with relevant
information. The Exchange states that the Adviser believes that the
price at which Shares trade will continue to be disciplined by
arbitrage opportunities created by the ability to purchase or redeem
creation Shares at their NAV, which should ensure that Shares will not
trade at a material discount or premium in relation to their NAV.
The Exchange states that, according to the Adviser, there will not
be any significant impacts to the settlement or operational aspects of
the Fund's arbitrage mechanism due to the use of derivatives. Because
derivatives generally are not eligible for in-kind transfer, they will
typically be substituted with a ``cash in lieu'' amount when the Fund
processes purchases or redemptions of creation units in-kind.
Surveillance
The Exchange represents that trading in the Shares will be subject
to the existing trading surveillances, administered by the Financial
Industry Regulatory Authority (``FINRA'') on behalf of the Exchange,
which are designed to detect violations of Exchange rules and
applicable federal securities laws.\17\ The Exchange represents that
these procedures are adequate to properly monitor Exchange trading of
the Shares in all trading sessions and to deter and detect violations
of Exchange rules and applicable federal securities laws.
---------------------------------------------------------------------------
\17\ FINRA surveils trading on the Exchange pursuant to a
regulatory services agreement. The Exchange is responsible for
FINRA's performance under this regulatory services agreement.
---------------------------------------------------------------------------
The surveillances referred to above generally focus on detecting
securities trading outside their normal patterns,
[[Page 44228]]
which could be indicative of manipulative or other violative activity.
When such situations are detected, surveillance analysis follows and
investigations are opened, where appropriate, to review the behavior of
all relevant parties for all relevant trading violations.
FINRA, on behalf of the Exchange, will communicate as needed
regarding trading in the Shares, exchange traded options, futures, and
options on futures with other markets or other entities that are
members of the Intermarket Surveillance Group (``ISG''), and FINRA may
obtain trading information regarding trading in the Shares, exchange
traded options, futures, and options on futures from such markets or
entities. In addition, the Exchange may obtain information regarding
trading in the Shares, exchange traded options, futures, and options on
futures from markets or other entities that are members of ISG or with
which the Exchange has in place a comprehensive surveillance sharing
agreement.\18\ In addition, FINRA, on behalf of the Exchange, is able
to access, as needed, trade information for certain fixed income
securities held by the Fund reported to FINRA's Trade Reporting and
Compliance Engine (``TRACE''). The Exchange also states that it has a
general policy prohibiting the distribution of material, non-public
information by its employees.
---------------------------------------------------------------------------
\18\ For a list of the current members of ISG, see
www.isgportal.org. The Exchange notes that not all components of the
Disclosed Portfolio for the Fund may trade on markets that are
members of ISG or with which the Exchange has in place a
comprehensive surveillance sharing agreement.
---------------------------------------------------------------------------
Additional information regarding the Trust, the Fund, and the
Shares, including investment strategies, risks, NAV calculation,
creation and redemption procedures, fees, portfolio holdings,
disclosure policies, distributions and taxes is included in the Prior
Release, Notice, and the Registration Statement, as applicable.\19\
---------------------------------------------------------------------------
\19\ See supra notes 9, 3, and 10.
---------------------------------------------------------------------------
III. Discussion and Commission's Findings
The Commission has carefully reviewed the proposed rule change and
finds that it is consistent with the requirements of Section 6 of the
Act \20\ and the rules and regulations thereunder applicable to a
national securities exchange.\21\ In particular, the Commission finds
that the proposal is consistent with Section 6(b)(5) of the Act,\22\
which requires, among other things, that the Exchange's rules be
designed to prevent fraudulent and manipulative acts and practices, to
promote just and equitable principles of trade, to foster cooperation
and coordination with persons engaged in facilitating transactions in
securities, to remove impediments to, and perfect the mechanism of, a
free and open market and a national market system, and, in general, to
protect investors and the public interest. The Commission notes that
the Fund and the Shares must comply with the requirements of NYSE Arca
Equities Rule 8.600 to continue to be listed and traded on the
Exchange.
---------------------------------------------------------------------------
\20\ 15 U.S.C. 78f.
\21\ In approving this proposed rule change, the Commission has
considered the proposed rule's impact on efficiency, competition,
and capital formation. See 15 U.S.C. 78c(f).
\22\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------
The Commission notes that, with respect to its proposed investments
in derivatives, the Fund will seek, where possible, to use
counterparties whose financial status is such that the risk of default
is reduced. The Exchange states that PIMCO's Counterparty Risk
Committee will evaluate the creditworthiness of counterparties on an
ongoing basis. In addition to information provided by credit agencies,
PIMCO credit analysts will evaluate each approved counterparty using
various methods of analysis, including company visits, earnings
updates, the broker-dealer's reputation, PIMCO's past experience with
the broker-dealer, market levels for the counterparty's debt and
equity, the counterparty's liquidity, and its share of market
participation.
In addition, according to the Exchange, the proposed investments in
derivative instruments will be made in accordance with the 1940 Act and
consistent with the Fund's investment objective and policies. To
further limit the potential risk associated with such transactions, the
Fund will segregate or ``earmark'' assets determined to be liquid by
PIMCO in accordance with procedures established by the Trust's Board of
Trustees and in accordance with the 1940 Act (or, as permitted by
applicable regulation, enter into certain offsetting positions) to
cover its obligations under the proposed derivative instruments. The
Exchange represents that these procedures have been adopted consistent
with Section 18 of the 1940 Act and related Commission guidance. In
addition, with respect to the proposed investments in derivative
instruments, the Exchange states that appropriate risk disclosures will
be provided in the Fund's offering documents, including leveraging
risk. The Exchange further represents that the Fund's investments,
including the proposed investments in derivative instruments, are
subject to all of the restrictions under the 1940 Act, including
restrictions with respect to illiquid securities.
Further, the Commission notes that the Fund's disclosure of
derivative positions in the Disclosed Portfolio will include
information that market participants can use to value these positions
intraday. This information will include, as applicable to the type of
holding: Ticker symbol, CUSIP number or other identifier, if any; a
description of the holding (including the type of holding, such as the
type of swap); the identity of the security, commodity, index or other
asset or instrument underlying the holding, if any; for options, the
option strike price; quantity held (as measured by, for example, par
value, notional value or number of shares, contracts or units);
maturity date, if any; coupon rate, if any; effective date, if any;
market value of the holding; and the percentage weighting of the
holding in the Fund's portfolio.
The Exchange states that there will be minimal, if any, impact to
the arbitrage mechanism as a result of the use of derivatives. Market
makers and participants should be able to value derivatives as long as
the positions are disclosed with relevant information. The Exchange
notes that the price at which Shares trade will continue to be
disciplined by arbitrage opportunities created by the ability to
purchase or redeem creation Shares at their NAV, which should ensure
that Shares will not trade at a material discount or premium in
relation to their NAV. In addition, the Exchange notes that there will
not be any significant impacts to the settlement or operational aspects
of the Fund's arbitrage mechanism due to the use of derivatives.
In support of this proposal, the Exchange has made additional
representations, including:
(1) The Adviser has managed and will continue to manage the Fund in
the manner described in the Prior Release.
(2) There is no change to the Fund's investment objective.
(3) The Fund will continue to comply with all initial and continued
listing requirements under NYSE Arca Equities Rule 8.600.
(4) FINRA, on behalf of the Exchange, will communicate as needed
regarding trading in the Shares, exchange traded options, futures, and
options on futures with other markets or other entities that are
members of the ISG, and FINRA may obtain trading information regarding
trading in the Shares, exchange traded options, futures, and options on
futures from such markets or entities. In addition, the Exchange may
obtain information regarding trading in the
[[Page 44229]]
Shares, exchange traded options, futures, and options on futures from
markets or other entities that are members of ISG or with which the
Exchange has in place a comprehensive surveillance sharing agreement.
In addition, FINRA, on behalf of the Exchange, is able to access, as
needed, trade information for certain fixed income securities held by
the Fund reported to FINRA's TRACE.
(5) The Fund will comply with the representations as prescribed in
the No-Action Letter.
(6) Except for the proposed changes, all other facts presented and
representations made in the Prior Release remain unchanged.
This approval order is based on the Exchange's representations and
description of the Fund, including those set forth above and in the
Notice. For the foregoing reasons, the Commission finds that the
proposed rule change, as modified by Amendment No. 2, is consistent
with Section 6(b)(5) of the Act \23\ and the rules and regulations
thereunder applicable to a national securities exchange.
---------------------------------------------------------------------------
\23\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------
IV. Conclusion
It is therefore ordered, pursuant to Section 19(b)(2) of the
Act,\24\ that the proposed rule change (SR-NYSEArca-2013-122) as
modified by Amendment No. 2 thereto be, and it hereby is, approved.
---------------------------------------------------------------------------
\24\ 15 U.S.C. 78s(b)(2).
For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\25\
Kevin M. O'Neill,
Deputy Secretary.
---------------------------------------------------------------------------
\25\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------
[FR Doc. 2014-17880 Filed 7-29-14; 8:45 am]
BILLING CODE 8011-01-P